nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—Toll-Like Receptors Cascades—CTSS—intracranial aneurysm	0.0401	0.0419	CbGpPWpGaD
Naloxone—TLR4—Toll-Like Receptors Cascades—CTSK—intracranial aneurysm	0.0369	0.0386	CbGpPWpGaD
Naloxone—TLR4—Toll-Like Receptors Cascades—CTSB—intracranial aneurysm	0.0305	0.0319	CbGpPWpGaD
Naloxone—TLR4—MyD88:Mal cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.0273	0.0285	CbGpPWpGaD
Naloxone—TLR4—MyD88-independent cascade—AGER—intracranial aneurysm	0.0261	0.0274	CbGpPWpGaD
Naloxone—TLR4—Activated TLR4 signalling—AGER—intracranial aneurysm	0.0235	0.0246	CbGpPWpGaD
Naloxone—TLR4—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.0221	0.0231	CbGpPWpGaD
Naloxone—TLR4—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.0197	0.0206	CbGpPWpGaD
Naloxone—TLR4—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.0177	0.0185	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.0171	0.0179	CbGpPWpGaD
Naloxone—OPRD1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.0167	0.0175	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—CCL2—intracranial aneurysm	0.0163	0.017	CbGpPWpGaD
Naloxone—OPRK1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.0147	0.0153	CbGpPWpGaD
Naloxone—CREB1—Toll-Like Receptors Cascades—CTSS—intracranial aneurysm	0.014	0.0146	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CTSS—intracranial aneurysm	0.013	0.0136	CbGpPWpGaD
Naloxone—CREB1—Toll-Like Receptors Cascades—CTSK—intracranial aneurysm	0.0129	0.0135	CbGpPWpGaD
Naloxone—OPRM1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.0124	0.013	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CTSK—intracranial aneurysm	0.0119	0.0125	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—MMP9—intracranial aneurysm	0.0117	0.0122	CbGpPWpGaD
Naloxone—CREB1—TRAF6 Mediated Induction of proinflammatory cytokines—AGER—intracranial aneurysm	0.0114	0.0119	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.0112	0.0117	CbGpPWpGaD
Naloxone—CREB1—Toll-Like Receptors Cascades—CTSB—intracranial aneurysm	0.0107	0.0111	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—NCF1—intracranial aneurysm	0.0104	0.0109	CbGpPWpGaD
Naloxone—CREB1—MyD88 cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.0103	0.0108	CbGpPWpGaD
Naloxone—CREB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—intracranial aneurysm	0.0102	0.0107	CbGpPWpGaD
Naloxone—CREB1—MyD88 dependent cascade initiated on endosome—AGER—intracranial aneurysm	0.01	0.0105	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CTSB—intracranial aneurysm	0.00989	0.0103	CbGpPWpGaD
Naloxone—CREB1—Toll Like Receptor 9 (TLR9) Cascade—AGER—intracranial aneurysm	0.00968	0.0101	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00956	0.01	CbGpPWpGaD
Naloxone—CREB1—MyD88:Mal cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00951	0.00995	CbGpPWpGaD
Naloxone—CREB1—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.00942	0.00986	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—CST3—intracranial aneurysm	0.00918	0.0096	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.00917	0.00959	CbGpPWpGaD
Naloxone—CREB1—MyD88-independent cascade—AGER—intracranial aneurysm	0.00913	0.00955	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—CCL2—intracranial aneurysm	0.00864	0.00904	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—MMP2—intracranial aneurysm	0.00826	0.00864	CbGpPWpGaD
Naloxone—CREB1—Activated TLR4 signalling—AGER—intracranial aneurysm	0.00821	0.00859	CbGpPWpGaD
Naloxone—ESR1—FOXM1 transcription factor network—MMP2—intracranial aneurysm	0.0081	0.00847	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00786	0.00822	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—NOS3—intracranial aneurysm	0.00774	0.00809	CbGpPWpGaD
Naloxone—CREB1—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.00772	0.00808	CbGpPWpGaD
Naloxone—TLR4—Immune System—CTSS—intracranial aneurysm	0.00756	0.00791	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—NOS3—intracranial aneurysm	0.00729	0.00762	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.00714	0.00747	CbGpPWpGaD
Naloxone—TLR4—Immune System—CTSK—intracranial aneurysm	0.00696	0.00728	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00689	0.00721	CbGpPWpGaD
Naloxone—CREB1—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.00688	0.0072	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—AGER—intracranial aneurysm	0.00638	0.00668	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00626	0.00655	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—MMP9—intracranial aneurysm	0.00621	0.00649	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.00619	0.00647	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.00618	0.00646	CbGpPWpGaD
Naloxone—ESR1—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.00617	0.00646	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00615	0.00644	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—TIMP1—intracranial aneurysm	0.00607	0.00635	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00583	0.00609	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00578	0.00605	CbGpPWpGaD
Naloxone—TLR4—Immune System—CTSB—intracranial aneurysm	0.00576	0.00602	CbGpPWpGaD
Naloxone—TLR4—Immune System—NCF1—intracranial aneurysm	0.00573	0.00599	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—CCL2—intracranial aneurysm	0.00566	0.00592	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—STARD13—intracranial aneurysm	0.0056	0.00586	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00559	0.00585	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—STARD13—intracranial aneurysm	0.00558	0.00584	CbGpPWpGaD
Naloxone—CREB1—Disease—SLC25A16—intracranial aneurysm	0.00554	0.0058	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0054	0.00564	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00527	0.00552	CbGpPWpGaD
Naloxone—TLR4—cerebellum—intracranial aneurysm	0.00504	0.114	CbGeAlD
Naloxone—OPRK1—Signaling Pathways—STARD13—intracranial aneurysm	0.00489	0.00512	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—NOS3—intracranial aneurysm	0.00477	0.00499	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00462	0.00484	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00456	0.00477	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CTSS—intracranial aneurysm	0.00453	0.00474	CbGpPWpGaD
Naloxone—CREB1—brainstem—intracranial aneurysm	0.0045	0.102	CbGeAlD
Naloxone—ALB—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.0044	0.0046	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CTSS—intracranial aneurysm	0.00435	0.00455	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CTSK—intracranial aneurysm	0.00417	0.00436	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—STARD13—intracranial aneurysm	0.00414	0.00433	CbGpPWpGaD
Naloxone—TLR4—brain—intracranial aneurysm	0.00409	0.0929	CbGeAlD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.00408	0.00426	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.00405	0.00423	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00402	0.0042	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CTSK—intracranial aneurysm	0.004	0.00419	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.00393	0.00412	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00391	0.00409	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00387	0.00405	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC25A16—intracranial aneurysm	0.00376	0.00393	CbGpPWpGaD
Naloxone—TLR4—Immune System—AGER—intracranial aneurysm	0.00372	0.00389	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—STARD13—intracranial aneurysm	0.00367	0.00384	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—CCL2—intracranial aneurysm	0.00358	0.00375	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.00353	0.00369	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00352	0.00368	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CTSB—intracranial aneurysm	0.00345	0.00361	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.0034	0.00355	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CTSB—intracranial aneurysm	0.00331	0.00347	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00331	0.00347	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—NCF1—intracranial aneurysm	0.0033	0.00345	CbGpPWpGaD
Naloxone—CREB1—medulla oblongata—intracranial aneurysm	0.00314	0.0712	CbGeAlD
Naloxone—OPRM1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00298	0.00311	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00287	0.003	CbGpPWpGaD
Naloxone—CREB1—midbrain—intracranial aneurysm	0.00287	0.0651	CbGeAlD
Naloxone—ALB—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00284	0.00298	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00275	0.00287	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00273	0.00286	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00269	0.00282	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTSS—intracranial aneurysm	0.00264	0.00276	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.0026	0.00272	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ASAH1—intracranial aneurysm	0.00249	0.0026	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTSK—intracranial aneurysm	0.00243	0.00254	CbGpPWpGaD
Naloxone—OPRM1—brainstem—intracranial aneurysm	0.00243	0.0551	CbGeAlD
Naloxone—CREB1—Axon guidance—MMP2—intracranial aneurysm	0.00241	0.00252	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00228	0.00238	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00227	0.00237	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—AGER—intracranial aneurysm	0.00223	0.00233	CbGpPWpGaD
Naloxone—CREB1—cerebellum—intracranial aneurysm	0.00222	0.0504	CbGeAlD
Naloxone—CREB1—Disease—CST3—intracranial aneurysm	0.00212	0.00222	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00207	0.00216	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00206	0.00216	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTSB—intracranial aneurysm	0.00201	0.0021	CbGpPWpGaD
Naloxone—CREB1—Immune System—NCF1—intracranial aneurysm	0.002	0.00209	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00199	0.00208	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CCL2—intracranial aneurysm	0.00198	0.00207	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00193	0.00201	CbGpPWpGaD
Naloxone—CREB1—Disease—NCF1—intracranial aneurysm	0.00185	0.00193	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC25A16—intracranial aneurysm	0.00185	0.00193	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC25A16—intracranial aneurysm	0.00184	0.00192	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—MMP9—intracranial aneurysm	0.00181	0.0019	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00181	0.00189	CbGpPWpGaD
Naloxone—CREB1—brain—intracranial aneurysm	0.0018	0.0409	CbGeAlD
Naloxone—ESR1—brainstem—intracranial aneurysm	0.00177	0.0402	CbGeAlD
Naloxone—OPRK1—GPCR ligand binding—CCL2—intracranial aneurysm	0.00173	0.00181	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP2—intracranial aneurysm	0.00172	0.0018	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00168	0.00176	CbGpPWpGaD
Naloxone—OPRK1—cerebellum—intracranial aneurysm	0.00168	0.0382	CbGeAlD
Naloxone—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.00161	0.00168	CbGpPWpGaD
Naloxone—OPRM1—midbrain—intracranial aneurysm	0.00155	0.0351	CbGeAlD
Naloxone—OPRM1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00153	0.0016	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CCL2—intracranial aneurysm	0.00147	0.00153	CbGpPWpGaD
Naloxone—SLCO1A2—medulla oblongata—intracranial aneurysm	0.00146	0.0331	CbGeAlD
Naloxone—OPRD1—brain—intracranial aneurysm	0.00142	0.0323	CbGeAlD
Naloxone—ALB—Hemostasis—TIMP1—intracranial aneurysm	0.00139	0.00145	CbGpPWpGaD
Naloxone—OPRK1—brain—intracranial aneurysm	0.00137	0.031	CbGeAlD
Naloxone—SLCO1A2—midbrain—intracranial aneurysm	0.00133	0.0302	CbGeAlD
Naloxone—CREB1—Immune System—AGER—intracranial aneurysm	0.0013	0.00136	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP9—intracranial aneurysm	0.00129	0.00135	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NCF1—intracranial aneurysm	0.00129	0.00135	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NCF1—intracranial aneurysm	0.00129	0.00135	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ASAH1—intracranial aneurysm	0.00122	0.00128	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00122	0.00128	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00122	0.00127	CbGpPWpGaD
Naloxone—ALB—Metabolism—ASAH1—intracranial aneurysm	0.00122	0.00127	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NCF1—intracranial aneurysm	0.00113	0.00118	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00107	0.00112	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.00107	0.00111	CbGpPWpGaD
Naloxone—SLCO1A2—cerebellum—intracranial aneurysm	0.00103	0.0234	CbGeAlD
Naloxone—CREB1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00102	0.00107	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00102	0.00106	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000991	0.00104	CbGpPWpGaD
Naloxone—OPRM1—brain—intracranial aneurysm	0.000971	0.0221	CbGeAlD
Naloxone—OPRM1—Signaling Pathways—NCF1—intracranial aneurysm	0.000955	0.000999	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000902	0.000944	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00089	0.000931	CbGpPWpGaD
Naloxone—ESR1—cerebellum—intracranial aneurysm	0.000873	0.0198	CbGeAlD
Naloxone—ESR1—Signaling Pathways—NCF1—intracranial aneurysm	0.000847	0.000886	CbGpPWpGaD
Naloxone—SLCO1A2—brain—intracranial aneurysm	0.000836	0.019	CbGeAlD
Naloxone—ALB—brain—intracranial aneurysm	0.000831	0.0189	CbGeAlD
Naloxone—ESR1—Signaling Pathways—EDNRA—intracranial aneurysm	0.0008	0.000837	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS3—intracranial aneurysm	0.000766	0.000801	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000752	0.000787	CbGpPWpGaD
Naloxone—ESR1—brain—intracranial aneurysm	0.000709	0.0161	CbGeAlD
Naloxone—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	0.000656	0.000687	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS3—intracranial aneurysm	0.000626	0.000655	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCL2—intracranial aneurysm	0.000602	0.000629	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCL2—intracranial aneurysm	0.0006	0.000627	CbGpPWpGaD
Naloxone—CYP2C8—brain—intracranial aneurysm	0.000584	0.0133	CbGeAlD
Naloxone—CREB1—Signaling Pathways—NOS3—intracranial aneurysm	0.000536	0.000561	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOS3—intracranial aneurysm	0.000535	0.000559	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCL2—intracranial aneurysm	0.000526	0.00055	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—NOS3—intracranial aneurysm	0.000519	0.000543	CbGpPWpGaD
Naloxone—ABCB1—medulla oblongata—intracranial aneurysm	0.000488	0.0111	CbGeAlD
Naloxone—OPRK1—Signaling Pathways—NOS3—intracranial aneurysm	0.000469	0.00049	CbGpPWpGaD
Naloxone—ABCB1—midbrain—intracranial aneurysm	0.000446	0.0101	CbGeAlD
Naloxone—OPRM1—Signaling Pathways—CCL2—intracranial aneurysm	0.000445	0.000465	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—intracranial aneurysm	0.00043	0.00045	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—intracranial aneurysm	0.000429	0.000449	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOS3—intracranial aneurysm	0.000396	0.000414	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCL2—intracranial aneurysm	0.000394	0.000412	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—intracranial aneurysm	0.000376	0.000393	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOS3—intracranial aneurysm	0.000351	0.000367	CbGpPWpGaD
Naloxone—ABCB1—cerebellum—intracranial aneurysm	0.000345	0.00783	CbGeAlD
Naloxone—OPRM1—Signaling Pathways—MMP9—intracranial aneurysm	0.000318	0.000333	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—intracranial aneurysm	0.000282	0.000295	CbGpPWpGaD
Naloxone—ABCB1—brain—intracranial aneurysm	0.00028	0.00636	CbGeAlD
Naloxone—CYP2C8—Metabolism—NOS3—intracranial aneurysm	0.000255	0.000267	CbGpPWpGaD
Naloxone—ALB—Metabolism—NOS3—intracranial aneurysm	0.000254	0.000265	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NOS3—intracranial aneurysm	0.000222	0.000233	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NOS3—intracranial aneurysm	0.000137	0.000143	CbGpPWpGaD
